Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of SLE for at least 6 months as defined by the most recent American College of Rheumatology criteria
Presence of lupus related inflammatory arthritis with at least four tender and four swollen joints; and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) ≥ 6 at screening;
You may not be if
Presence or history of vasculitis, and presence or history of active lupus nephritis requiring therapy within the last 3 years
Any disorder (including psychiatric), condition, clinically significant disease, disease activity related to SLE
Positive for HIV antibodies, hepatitis B surface antigen or anti-HBc, or hepatitis C antibodies
Known residential exposure to an individual with tuberculosis or positive Quantiferon test or PPD test at screening
Men and women of reproductive potential, unwilling to practice a highly effective method of birth control for the duration of the study
Clareo Health | Safety Study of AMG 557 in Subjects With Lupus Arthritis
